BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allegretti JR, Mullish BH, Kelly C, Fischer M. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet. 2019;394:420-431. [PMID: 31379333 DOI: 10.1016/s0140-6736(19)31266-8] [Cited by in Crossref: 158] [Cited by in F6Publishing: 163] [Article Influence: 52.7] [Reference Citation Analysis]
Number Citing Articles
1 Pan H, Jian Y, Wang F, Yu S, Guo J, Kan J, Guo W. NLRP3 and Gut Microbiota Homeostasis: Progress in Research. Cells 2022;11:3758. [DOI: 10.3390/cells11233758] [Reference Citation Analysis]
2 Tian P, Gao J, Liang L, Cui B, Hu Q, Zhou W, Li B, Liu Y, Chen T, Rao J, Wei H. Fecal Microbiota Transplantation Could Improve Chronic Diarrhea in Cynomolgus Monkey by Alleviating Inflammation and Modulating Gut Microbiota. Biomedicines 2022;10:3016. [DOI: 10.3390/biomedicines10123016] [Reference Citation Analysis]
3 Rosalia M, Chiesa E, Tottoli EM, Dorati R, Genta I, Conti B, Pisani S. Tobramycin Nanoantibiotics and Their Advantages: A Minireview. IJMS 2022;23:14080. [DOI: 10.3390/ijms232214080] [Reference Citation Analysis]
4 Ma J, Chen T, Ma X, Zhang B, Zhang J, Xu L, Wang Y, Huang J, Liu Z, Wang F, Tang X. Comprehensive bibliometric and visualized analysis of research on fecal microbial transplantation published from 2000 to 2021. BioMed Eng OnLine 2022;21:78. [DOI: 10.1186/s12938-022-01046-y] [Reference Citation Analysis]
5 Jia J, Zheng W, Zhang C, Zhang P, Guo X, Song S, Ai C. Fucoidan from Scytosiphon lomentaria protects against destruction of intestinal barrier, inflammation and lipid abnormality by modulating the gut microbiota in dietary fibers-deficient mice. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.144] [Reference Citation Analysis]
6 Malard F, Gaugler B, Mohty M. Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice. The Lancet Haematology 2022;9:e776-e785. [DOI: 10.1016/s2352-3026(22)00223-x] [Reference Citation Analysis]
7 Wang Y, Zhang S, Borody TJ, Zhang F. Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Chinese Medical Journal 2022;Publish Ahead of Print. [DOI: 10.1097/cm9.0000000000002339] [Reference Citation Analysis]
8 Štofilová J, Kvaková M, Kamlárová A, Hijová E, Bertková I, Guľašová Z. Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. Biomedicines 2022;10:2236. [DOI: 10.3390/biomedicines10092236] [Reference Citation Analysis]
9 Li X, Li M, Han J, Liu C, Han X, Wang K, Qiao R, Li X, Li X. Correlation between fat accumulation and fecal microbiota in crossbred pigs. J Microbiol 2022. [DOI: 10.1007/s12275-022-2218-5] [Reference Citation Analysis]
10 Daoust L, Choi BS, Agrinier A, Varin TV, Ouellette A, Mitchell PL, Samson N, Pilon G, Levy E, Desjardins Y, Laplante M, Anhê FF, Houde VP, Marette A. Gnotobiotic mice housing conditions critically influence the phenotype associated with transfer of faecal microbiota in a context of obesity. Gut. [DOI: 10.1136/gutjnl-2021-326475] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang M, Xie X, Zhao S, Han W, Zhang Y. Global research trends and hotspots of fecal microbiota transplantation: A bibliometric and visualization study. Front Microbiol 2022;13:990800. [DOI: 10.3389/fmicb.2022.990800] [Reference Citation Analysis]
12 Elfadil D, Elkhatib WF, El-Sayyad GS. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections. Microb Pathog 2022;170:105721. [PMID: 35970290 DOI: 10.1016/j.micpath.2022.105721] [Reference Citation Analysis]
13 Lamberte LE, van Schaik W. Antibiotic resistance in the commensal human gut microbiota. Current Opinion in Microbiology 2022;68:102150. [DOI: 10.1016/j.mib.2022.102150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Van Meijel RLJ, Venema K, Canfora EE, Blaak EE, Goossens GH. Mild intermittent hypoxia exposure alters gut microbiota composition in men with overweight and obesity. Benef Microbes 2022;:1-10. [PMID: 35866596 DOI: 10.3920/BM2021.0159] [Reference Citation Analysis]
15 Yang L, Hung LY, Zhu Y, Ding S, Margolis KG, Leong KW. Material Engineering in Gut Microbiome and Human Health. Research 2022;2022:1-32. [DOI: 10.34133/2022/9804014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Bu F, Yao X, Lu Z, Yuan X, Chen C, Li L, Li Y, Jiang F, Zhu L, Shi G, Chen Y. Pathogenic or Therapeutic: The Mediating Role of Gut Microbiota in Non-Communicable Diseases. Front Cell Infect Microbiol 2022;12:906349. [DOI: 10.3389/fcimb.2022.906349] [Reference Citation Analysis]
17 Gubatan J, Boye TL, Temby M, Sojwal RS, Holman DR, Sinha SR, Rogalla SR, Nielsen OH. Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer. Microorganisms 2022;10:1371. [DOI: 10.3390/microorganisms10071371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Qu Z, Tian P, Yang B, Zhao J, Wang G, Chen W. Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice. Life Sci 2022;304:120719. [PMID: 35716734 DOI: 10.1016/j.lfs.2022.120719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Lu G, Zhang F. The levels and core delivery ways of gut microbial reconstruction. Sci Sin -Vitae 2022. [DOI: 10.1360/ssv-2021-0381] [Reference Citation Analysis]
21 Lu G, Wang W, Li P, Wen Q, Cui B, Zhang F. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol 2022. [PMID: 35576458 DOI: 10.1111/1751-7915.14074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Kim AJ, Hong DS, George GC. Dietary Influences On Symptomatic And Non-Symptomatic Toxicities During Cancer Treatment: A Narrative Review. Cancer Treatment Reviews 2022. [DOI: 10.1016/j.ctrv.2022.102408] [Reference Citation Analysis]
23 Shang L, Tu J, Dai Z, Zeng X, Qiao S. Microbiota Transplantation in an Antibiotic-Induced Bacterial Depletion Mouse Model: Reproducible Establishment, Analysis, and Application. Microorganisms 2022;10:902. [PMID: 35630347 DOI: 10.3390/microorganisms10050902] [Reference Citation Analysis]
24 Hao Y, Feng Y, Yan X, Chen L, Zhong R, Tang X, Shen W, Sun Q, Sun Z, Ren Y, Zhang H, Zhao Y. Gut microbiota-testis axis: FMT improves systemic and testicular micro-environment to increase semen quality in type 1 diabetes. Mol Med 2022;28:45. [PMID: 35468731 DOI: 10.1186/s10020-022-00473-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Su W, Du Y, Lian F, Wu H, Zhang X, Yang W, Duan Y, Pan Y, Liu W, Wu A, Zhao B, Wu C, Wu S. Standards for Collection, Preservation, and Transportation of Fecal Samples in TCM Clinical Trials. Front Cell Infect Microbiol 2022;12:783682. [DOI: 10.3389/fcimb.2022.783682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gaonkar P. Safety and Potential Risks with Fecal Microbiota Transplantation. Contemporary Topics in Patient Safety - Volume 1 2022. [DOI: 10.5772/intechopen.95907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Pérez-Nadales E, Cano Á, Recio M, Artacho MJ, Guzmán-Puche J, Doblas A, Vidal E, Natera C, Martínez-Martínez L, Torre-Cisneros J, Castón JJ. Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing Klebsiella pneumoniae (KAPEDIS). BMJ Open 2022;12:e058124. [PMID: 35387830 DOI: 10.1136/bmjopen-2021-058124] [Reference Citation Analysis]
28 Li M, Yang L, Mu C, Sun Y, Gu Y, Chen D, Liu T, Cao H. Gut Microbial Metabolome in Inflammatory Bowel Disease: from Association to Therapeutic Perspectives. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.03.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Preiningerova JL, Jiraskova Zakostelska Z, Srinivasan A, Ticha V, Kovarova I, Kleinova P, Tlaskalova-hogenova H, Kubala Havrdova E. Multiple Sclerosis and Microbiome. Biomolecules 2022;12:433. [DOI: 10.3390/biom12030433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Cibulková I, Řehořová V, Duška F. Importance of intestinal microbiota in critically ill patients and possibilities of its influence. Anest intenziv Med 2022;33:32-38. [DOI: 10.36290/aim.2022.003] [Reference Citation Analysis]
31 Fan L, Ren J, Chen Y, Wang Y, Guo Z, Bu P, Yang J, Ma W, Zhu B, Zhao Y, Cai J. Effect of fecal microbiota transplantation on primary hypertension and the underlying mechanism of gut microbiome restoration: protocol of a randomized, blinded, placebo-controlled study. Trials 2022;23:178. [PMID: 35209934 DOI: 10.1186/s13063-022-06086-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:733992. [DOI: 10.3389/fcimb.2022.733992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
33 Patangia DV, Anthony Ryan C, Dempsey E, Paul Ross R, Stanton C. Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen 2022;11. [DOI: 10.1002/mbo3.1260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
34 Ponce-alonso M, García-fernández S, Blanco AM, Aroco CL, Rodríguez-jiménez C, del Campo Moreno R. Fecal microbiota transfer: Basic and clinical aspects, current applications, and future perspectives. Human-Gut Microbiome 2022. [DOI: 10.1016/b978-0-323-91313-3.00005-2] [Reference Citation Analysis]
35 Tembhre MK, Chawla MK, Berthiaume F, Kumar S. Relationship Between Probiotics and Gut-Skin Axis in Skin Wound Healing: A Recent Update. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-5628-6_8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Hiippala K, Khan I, Ronkainen A, Boulund F, Vähä-Mäkilä H, Suutarinen M, Seifert M, Engstrand L, Satokari R. Novel strain of Pseudoruminococcus massiliensis possesses traits important in gut adaptation and host-microbe interactions. Gut Microbes 2022;14:2013761. [PMID: 34965174 DOI: 10.1080/19490976.2021.2013761] [Reference Citation Analysis]
37 Zhang Y, Xue X, Su S, Zhou H, Jin Y, Shi Y, Lin J, Wang J, Li X, Yang G, Philpott JR, Liang J. Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years. Ann Transl Med 2021;9:1619. [PMID: 34926663 DOI: 10.21037/atm-21-3683] [Reference Citation Analysis]
38 Hollingshead C, Ciricillo J, Kammeyer J. Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test. Case Rep Infect Dis 2021;2021:6696542. [PMID: 34912583 DOI: 10.1155/2021/6696542] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Gotoh K, Sakaguchi Y, Kato H, Osaki H, Jodai Y, Wakuda M, Také A, Hayashi S, Morita E, Sugie T, Ito Y, Ohmiya N. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome. Anaerobe 2021;73:102502. [PMID: 34896553 DOI: 10.1016/j.anaerobe.2021.102502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Fischer M, Khoruts A. Oral lyophilised microbiota for the treatment of ulcerative colitis. Lancet Gastroenterol Hepatol 2021:S2468-1253(21)00433-7. [PMID: 34863329 DOI: 10.1016/S2468-1253(21)00433-7] [Reference Citation Analysis]
41 Ding Z, Wang W, Zhang K, Ming F, Yangdai T, Xu T, Shi H, Bao Y, Yao H, Peng H, Han C, Jiang W, Liu J, Hou X, Lin R. Novel scheme for non-invasive gut bioinformation acquisition with a magnetically controlled sampling capsule endoscope. Gut 2021;70:2297-306. [PMID: 33452177 DOI: 10.1136/gutjnl-2020-322465] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
42 He J, He X, Ma Y, Yang L, Fang H, Shang S, Xia H, Lian G, Tang H, Wang Q, Wang J, Lin Z, Wen J, Liu Y, Zhai C, Wang W, Jiang X, Xuan J, Liu M, Lu S, Li X, Wang H, Ouyang C, Cao M, Lin A, Zhang B, Wu D, Chen Y, Xiao C. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China. Microb Cell Fact 2021;20:216. [PMID: 34838016 DOI: 10.1186/s12934-021-01705-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ghani R, Mullish BH, Davies FJ, Marchesi JR. How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection. Clin Microbiol Infect 2021:S1198-743X(21)00633-9. [PMID: 34826617 DOI: 10.1016/j.cmi.2021.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yadav M, Chauhan NS. Microbiome therapeutics: exploring the present scenario and challenges. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
45 Lv W, Cui Y, Xue G, Wang Z, Niu L, Chai X, Wang Y. Potential value and chemical characterization of gut microbiota derived nitrogen containing metabolites in feces from Periplaneta americana (L.) at different growth stages. Sci Rep 2021;11:21191. [PMID: 34707100 DOI: 10.1038/s41598-021-00182-0] [Reference Citation Analysis]
46 Baunwall SMD, Terveer EM, Dahlerup JF, Erikstrup C, Arkkila P, Vehreschild MJ, Ianiro G, Gasbarrini A, Sokol H, Kump PK, Satokari R, De Looze D, Vermeire S, Nakov R, Brezina J, Helms M, Kjeldsen J, Rode AA, Kousgaard SJ, Alric L, Trang-Poisson C, Scanzi J, Link A, Stallmach A, Kupcinskas J, Johnsen PH, Garborg K, Rodríguez ES, Serrander L, Brummer RJ, Galpérine KT, Goldenberg SD, Mullish BH, Williams HR, Iqbal TH, Ponsioen C, Kuijper EJ, Cammarota G, Keller JJ, Hvas CL. The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. Lancet Reg Health Eur 2021;9:100181. [PMID: 34693388 DOI: 10.1016/j.lanepe.2021.100181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
47 Lythgoe MP, Ghani R, Mullish BH, Marchesi JR, Krell J. The potential of fecal microbiota transplantation in oncology. Trends Microbiol 2021:S0966-842X(21)00243-2. [PMID: 34711461 DOI: 10.1016/j.tim.2021.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
48 Sturov NV, Popov SV, Zhukov VA. Pathogenetic Role and Possibilities for Correction of Gut Microbiota Disorders in Urinary Tract Infections. A&Ch 2021;66:100-108. [DOI: 10.37489/0235-2990-2021-66-7-8-100-108] [Reference Citation Analysis]
49 Cibulková I, Řehořová V, Hajer J, Duška F. Fecal Microbial Transplantation in Critically Ill Patients-Structured Review and Perspectives. Biomolecules 2021;11:1459. [PMID: 34680092 DOI: 10.3390/biom11101459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Secombe KR, Al-Qadami GH, Subramaniam CB, Bowen JM, Scott J, Van Sebille YZA, Snelson M, Cowan C, Clarke G, Gheorghe CE, Cryan JF, Wardill HR. Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols. Gut Microbes 2021;13:1979878. [PMID: 34586011 DOI: 10.1080/19490976.2021.1979878] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
51 Aggarwala V, Mogno I, Li Z, Yang C, Britton GJ, Chen-Liaw A, Mitcham J, Bongers G, Gevers D, Clemente JC, Colombel JF, Grinspan A, Faith J. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes. Nat Microbiol 2021;6:1309-18. [PMID: 34580445 DOI: 10.1038/s41564-021-00966-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
52 Innes AJ, Mullish BH, Ghani R, Szydlo RM, Apperley JF, Olavarria E, Palanicawandar R, Kanfer EJ, Milojkovic D, McDonald JAK, Brannigan ET, Thursz MR, Williams HRT, Davies FJ, Marchesi JR, Pavlů J. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation. Front Cell Infect Microbiol 2021;11:684659. [PMID: 34513724 DOI: 10.3389/fcimb.2021.684659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
53 Yang M, Gu Y, Li L, Liu T, Song X, Sun Y, Cao X, Wang B, Jiang K, Cao H. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients 2021;13:3143. [PMID: 34579027 DOI: 10.3390/nu13093143] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
54 Byrd AL, Liu M, Fujimura KE, Lyalina S, Nagarkar DR, Charbit B, Bergstedt J, Patin E, Harrison OJ, Quintana-Murci L, Mellman I, Duffy D, Albert ML; Milieu Intérieur Consortium. Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers. J Exp Med 2021;218:e20200606. [PMID: 33175106 DOI: 10.1084/jem.20200606] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
55 Murciano-Brea J, Garcia-Montes M, Geuna S, Herrera-Rincon C. Gut Microbiota and Neuroplasticity. Cells 2021;10:2084. [PMID: 34440854 DOI: 10.3390/cells10082084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
56 Desselberger U. Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases. Viruses 2021;13:1601. [PMID: 34452466 DOI: 10.3390/v13081601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Wang H, Yang F, Zhang S, Xin R, Sun Y. Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis 2021;7:70. [PMID: 34381040 DOI: 10.1038/s41531-021-00213-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
58 Xu HL, Zou LL, Chen MB, Wang H, Shen WM, Zheng QH, Cui WY. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis. PLoS One 2021;16:e0255160. [PMID: 34358238 DOI: 10.1371/journal.pone.0255160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
59 Marcon AR, Turvey S, Caulfield T. 'Gut health' and the microbiome in the popular press: a content analysis. BMJ Open 2021;11:e052446. [PMID: 34326057 DOI: 10.1136/bmjopen-2021-052446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
60 Stebbings S, Roberts R. The Interplay of Genes with the Gut Microbiota in the Aetiopathogenesis of Spondyloarthropathies and Crohn’s Disease: Implications for Future Therapeutic Targets. EMJ Rheumatol 2021. [DOI: 10.33590/emjrheumatol/21-00025] [Reference Citation Analysis]
61 Feng J, Tang YN, Zhou LX, Pan JS. Standardized Nursing Procedures for Fecal Microbiota Transplantation via Upper Endoscopy. Gastroenterol Nurs 2021;44:227-32. [PMID: 34176888 DOI: 10.1097/SGA.0000000000000577] [Reference Citation Analysis]
62 Ponce-Alonso M, García-Hoz C, Halperin A, Nuño J, Nicolás P, Martínez-Pérez A, Ocaña J, García-Pérez JC, Guerrero A, López-Sanromán A, Cantón R, Roy G, Del Campo R. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis. Front Immunol 2021;12:683387. [PMID: 34149723 DOI: 10.3389/fimmu.2021.683387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Mullish BH, Allegretti JR. The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211017725. [PMID: 34104212 DOI: 10.1177/17562848211017725] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
64 Zhang C, Franklin CL, Ericsson AC. Consideration of Gut Microbiome in Murine Models of Diseases. Microorganisms 2021;9:1062. [PMID: 34068994 DOI: 10.3390/microorganisms9051062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
65 Su F, Luo Y, Yu J, Shi J, Zhao Y, Yan M, Huang H, Tan Y. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review. Eur J Med Res 2021;26:37. [PMID: 33910622 DOI: 10.1186/s40001-021-00508-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
66 Danne C, Rolhion N, Sokol H. Recipient factors in faecal microbiota transplantation: one stool does not fit all. Nat Rev Gastroenterol Hepatol 2021;18:503-13. [PMID: 33907321 DOI: 10.1038/s41575-021-00441-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 31.0] [Reference Citation Analysis]
67 Wuethrich I, W Pelzer B, Khodamoradi Y, Vehreschild MJGT. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria. Gut Microbes 2021;13:1-13. [PMID: 33870869 DOI: 10.1080/19490976.2021.1911279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
68 Chen J, Zaman A, Ramakrishna B, Olesen SW. Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank. Front Cell Infect Microbiol 2021;11:622949. [PMID: 33937092 DOI: 10.3389/fcimb.2021.622949] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
69 Ramachandran C, Eric Banan-mwine D, Fazle E, Imran K, Shuai W, Su-jung Y, Kandasamy S, Inamul Hasan M, Sumaira M, Ghazala S, Marie A, Shanmugarathinam A, Thirumalai V, Myeong-hyeon W, Usha A, Devarajan T, Oh DH. Application of Next-Generation Sequencing Techniques in Food-Related Microbiome Studies. Sequencing Technologies in Microbial Food Safety and Quality 2021. [DOI: 10.1201/9780429329869-21] [Reference Citation Analysis]
70 Ojeda J, Ávila A, Vidal PM. Gut Microbiota Interaction with the Central Nervous System throughout Life. J Clin Med 2021;10:1299. [PMID: 33801153 DOI: 10.3390/jcm10061299] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
71 Shabbir U, Arshad MS, Sameen A, Oh DH. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients 2021;13:690. [PMID: 33669988 DOI: 10.3390/nu13020690] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 34.0] [Reference Citation Analysis]
72 Lila AM, Galushko EA, Gordeev AV, Semashko AS. The role of microbiome in the pathogenesis of immune-mediated inflammatory diseases: controversial issues. Sovremennaâ revmatologiâ 2021;15:15-19. [DOI: 10.14412/1996-7012-2021-1-15-19] [Reference Citation Analysis]
73 Xu F, Li N, Wang C, Xing H, Chen D, Wei Y. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterol 2021;21:54. [PMID: 33549047 DOI: 10.1186/s12876-021-01630-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
74 Fang H, Fu L, Li X, Lu C, Su Y, Xiong K, Zhang L. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Microb Cell Fact 2021;20:18. [PMID: 33468164 DOI: 10.1186/s12934-021-01513-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
75 Zhong M, Buch H, Wen Q, Long C, Cui B, Zhang F. Colonic Transendoscopic Enteral Tubing: Route for a Novel, Safe, and Convenient Delivery of Washed Microbiota Transplantation in Children. Gastroenterol Res Pract 2021;2021:6676962. [PMID: 33510783 DOI: 10.1155/2021/6676962] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
76 Samanta S, Shawcross DL. The gut microbiota in hepatic encephalopathy. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes 2021. [DOI: 10.1016/b978-0-12-821927-0.00006-1] [Reference Citation Analysis]
77 Hyde MK, Masser BM. Determinants of community members' willingness to donate stool for faecal microbiota transplantation. PLoS One 2020;15:e0243751. [PMID: 33301497 DOI: 10.1371/journal.pone.0243751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Hernandez CJ. Musculoskeletal microbiology: The utility of the microbiome in orthopedics. J Orthop Res 2021;39:251-7. [PMID: 33245146 DOI: 10.1002/jor.24927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
80 Olesen SW. Power calculations for detecting differences in efficacy of fecal microbiota donors. Contemp Clin Trials Commun 2020;20:100674. [PMID: 33241161 DOI: 10.1016/j.conctc.2020.100674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Nené NR, Barrett J, Jones A, Evans I, Reisel D, Timms JF, Paprotka T, Leimbach A, Franchi D, Colombo N, Bjørge L, Zikan M, Cibula D, Widschwendter M. DNA methylation signatures to predict the cervicovaginal microbiome status. Clin Epigenetics 2020;12:180. [PMID: 33228781 DOI: 10.1186/s13148-020-00966-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Han M, Zha Y, Chong H, Zhong C, Ning K. Utilizing microbiome approaches to assist source tracking, treatment and prevention of COVID-19: Review and assessment. Comput Struct Biotechnol J 2020;18:3615-22. [PMID: 33304459 DOI: 10.1016/j.csbj.2020.11.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
83 Li N, Zuo B, Huang S, Zeng B, Han D, Li T, Liu T, Wu Z, Wei H, Zhao J, Wang J. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation. Microbiome 2020;8:161. [PMID: 33208178 DOI: 10.1186/s40168-020-00917-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
84 Meriggi F, Zaniboni A. Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature. Cancer Immunol Immunother 2021;70:1511-7. [PMID: 33165628 DOI: 10.1007/s00262-020-02786-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
85 Marietta E, Mangalam AK, Taneja V, Murray JA. Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases. Front Immunol 2020;11:573079. [PMID: 33193357 DOI: 10.3389/fimmu.2020.573079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
86 Zhou H, Shi L, Ren Y, Tan X, Liu W, Liu Z. Applications of Human Skin Microbiota in the Cutaneous Disorders for Ecology-Based Therapy. Front Cell Infect Microbiol 2020;10:570261. [PMID: 33194808 DOI: 10.3389/fcimb.2020.570261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
87 Wen Q, Liu KJ, Cui BT, Li P, Wu X, Zhong M, Wei L, Tu H, Yuan Y, Lin D, Hsu WH, Wu DC, Yin H, Zhang FM. Impact of cap-assisted colonoscopy during transendoscopic enteral tubing: A randomized controlled trial. World J Gastroenterol 2020; 26(39): 6098-6110 [PMID: 33132658 DOI: 10.3748/wjg.v26.i39.6098] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Olesen SW, Zaman A, Osman M, Ramakrishna B. Modeling Donor Screening Strategies to Reduce the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission via Fecal Microbiota Transplantation. Open Forum Infect Dis 2020;7:ofaa499. [PMID: 33235890 DOI: 10.1093/ofid/ofaa499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
89 Zhang T, Ding X, Dai M, Zhang H, Xiao F, He X, Zhang F, Zhang X. Washed microbiota transplantation in patients with respiratory spreading diseases: Practice recommendations. Med Microecol. 2021;7:100024. [PMID: 34046562 DOI: 10.1016/j.medmic.2020.100024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Brown EG, Goldman SM. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. Neurotherapeutics 2020;17:1406-17. [PMID: 33034846 DOI: 10.1007/s13311-020-00942-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
91 Xu F, Fu Y, Sun TY, Jiang Z, Miao Z, Shuai M, Gou W, Ling CW, Yang J, Wang J, Chen YM, Zheng JS. The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases. Microbiome 2020;8:145. [PMID: 33032658 DOI: 10.1186/s40168-020-00923-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
92 Limas Solano LM, Vargas Niño CE, Valbuena Rodríguez DC, Ramírez López LX. Trasplante de microbiota fecal: una revisión. Rev Colomb Gastroenterol 2020;35:229-337. [DOI: 10.22516/25007440.486] [Reference Citation Analysis]
93 Aggarwala V, Mogno I, Li Z, Yang C, Britton GJ, Chen-liaw A, Mitcham J, Bongers G, Gevers D, Clemente JC, Colombel J, Grinspan A, Faith J. Quantification of discrete gut bacterial strains following fecal transplantation for recurrent Clostridioides difficile infection demonstrates long-term stable engraftment in non-relapsing recipients.. [DOI: 10.1101/2020.09.10.292136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Chen J, Zaman A, Ramakrishna B, Olesen SW, OpenBiome Team. Stool banking for fecal microbiota transplantation: methods and operations at a large stool bank.. [DOI: 10.1101/2020.09.03.20187583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Martinez-Gili L, McDonald JAK, Liu Z, Kao D, Allegretti JR, Monaghan TM, Barker GF, Miguéns Blanco J, Williams HRT, Holmes E, Thursz MR, Marchesi JR, Mullish BH. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut Microbes 2020;12:1810531. [PMID: 32893721 DOI: 10.1080/19490976.2020.1810531] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
96 Segal JP, Mullish BH, Quraishi MN, Iqbal T, Marchesi JR, Sokol H. Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease. Therap Adv Gastroenterol 2020;13:1756284820946904. [PMID: 32952613 DOI: 10.1177/1756284820946904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
97 Ianiro G, Mullish BH, Kelly CR, Kassam Z, Kuijper EJ, Ng SC, Iqbal TH, Allegretti JR, Bibbò S, Sokol H, Zhang F, Fischer M, Costello SP, Keller JJ, Masucci L, van Prehn J, Quaranta G, Quraishi MN, Segal J, Kao D, Satokari R, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota G. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 2020;69:1555-63. [PMID: 32620549 DOI: 10.1136/gutjnl-2020-321829] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 31.5] [Reference Citation Analysis]
98 Collij V, Klaassen MAY, Weersma RK, Vila AV. Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications. Hum Genet 2021;140:703-8. [PMID: 32857194 DOI: 10.1007/s00439-020-02218-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
99 Liu S, Gao J, Zhu M, Liu K, Zhang HL. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment. Mol Neurobiol 2020;57:5026-43. [PMID: 32829453 DOI: 10.1007/s12035-020-02073-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 58] [Article Influence: 39.5] [Reference Citation Analysis]
100 Cocking JH, Turley SR, Fofanov VY, Samuels-crow K, Hungate B, Mau RL, Keim PS, Caporaso JG, Hepp C. Forensic analysis of Soil Microbiomes: Linking Evidence to a Geographic Location.. [DOI: 10.1101/2020.07.10.198044] [Reference Citation Analysis]
101 Hvas CL, Baunwall SMD, Erikstrup C. Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity. EClinicalMedicine 2020;24:100436. [PMID: 32642633 DOI: 10.1016/j.eclinm.2020.100436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
102 Duquenoy A, Bellais S, Gasc C, Schwintner C, Dore J, Thomas V. Assessment of Gram- and Viability-Staining Methods for Quantifying Bacterial Community Dynamics Using Flow Cytometry. Front Microbiol 2020;11:1469. [PMID: 32676069 DOI: 10.3389/fmicb.2020.01469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
103 Olesen SW, Zaman A, Osman M, Ramakrishna B. Modelling donor screening strategies to reduce the risk of SARS-CoV-2 via fecal microbiota transplantation.. [DOI: 10.1101/2020.06.24.169094] [Reference Citation Analysis]
104 Thomann AK, Mak JWY, Zhang JW, Wuestenberg T, Ebert MP, Sung JJY, Bernstein ÇN, Reindl W, Ng SC. Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:247-66. [PMID: 32525605 DOI: 10.1111/apt.15787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
105 Choi BS, Daoust L, Pilon G, Marette A, Tremblay A. Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification. Int J Obes (Lond) 2020;44:1818-31. [PMID: 32523034 DOI: 10.1038/s41366-020-0618-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
106 Merrick B, Allen L, Masirah M Zain N, Forbes B, Shawcross DL, Goldenberg SD. Regulation, risk and safety of Faecal Microbiota Transplant. Infect Prev Pract 2020;2:100069. [PMID: 34316559 DOI: 10.1016/j.infpip.2020.100069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
107 Bibbò S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, Gasbarrini A. Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. J Clin Med 2020;9:E1757. [PMID: 32517023 DOI: 10.3390/jcm9061757] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
108 Olesen SW. Power calculations for detecting differences in efficacy of fecal microbiota donors.. [DOI: 10.1101/2020.04.16.20068361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Honggang W, Xiaozhong Y. China’s contribution to gut microbiota research. Arch Community Med Public Health 2020;6:049-052. [DOI: 10.17352/2455-5479.000074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Mamoon L, Olesen SW. The public health impact of fecal microbiota transplantation.. [DOI: 10.1101/2020.04.07.20056952] [Reference Citation Analysis]
111 Vesterhus M, Karlsen TH. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities. J Gastroenterol 2020;55:588-614. [PMID: 32222826 DOI: 10.1007/s00535-020-01681-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
112 Fang H, Fu L, Li X, Wang J, Xiong K, Su Y, Zhang L. Long-term efficacy and safety of single fecal microbiota transplantation for recurrent active ulcerative colitis.. [DOI: 10.1101/2020.03.16.20022293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Graf EH, Pancholi P. Appropriate Use and Future Directions of Molecular Diagnostic Testing. Curr Infect Dis Rep 2020;22:5. [PMID: 32030534 DOI: 10.1007/s11908-020-0714-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
114 Mullish BH, Quraishi MN, Segal JP, Ianiro G, Iqbal TH. The gut microbiome: what every gastroenterologist needs to know. Frontline Gastroenterol 2021;12:118-27. [PMID: 33613943 DOI: 10.1136/flgastro-2019-101376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
115 Worley J, Delaney ML, Cummins CK, Dubois A, Klompas M, Bry L. Genomic determination of relative risks for Clostridioides difficile infection from asymptomatic carriage in ICU patients.. [DOI: 10.1101/2020.01.29.20019489] [Reference Citation Analysis]
116 Hsu BB, Way JC, Silver PA. Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut. mSystems 2020;5:e00013-20. [PMID: 31992629 DOI: 10.1128/mSystems.00013-20] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
117 Allegretti JR, Mullish BH. Faecal microbiota transplantations and urinary tract infections - Authors' reply. Lancet 2020;395:271. [PMID: 31982069 DOI: 10.1016/S0140-6736(19)32978-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Byrd AL, Liu M, Fujimura KE, Lyalina S, Nagarkar DR, Charbit B, Bergstedt J, Patin E, Harrison OJ, Quintana-murci L, Duffy D, Albert ML, The Milieu Intérieur Consortium. Stability and dynamics of the human gut microbiome and its association with systemic immune traits.. [DOI: 10.1101/2020.01.17.909853] [Reference Citation Analysis]
119 Leocádio PCL, Oriá RB, Crespo-Lopez ME, Alvarez-Leite JI. Obesity: More Than an Inflammatory, an Infectious Disease? Front Immunol 2019;10:3092. [PMID: 31993062 DOI: 10.3389/fimmu.2019.03092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
120 Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020;11:251-266. [PMID: 31919742 DOI: 10.1007/s13238-019-00684-8] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 39.5] [Reference Citation Analysis]
121 Xu F, Fu Y, Sun T, Jiang Z, Miao Z, Shuai M, Gou W, Ling C, Yang J, Wang J, Chen Y, Zheng J. The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for human complex diseases.. [DOI: 10.1101/2019.12.26.888313] [Reference Citation Analysis]
122 Quigley EMM. Commentary: faecal microbiota transplantation-from home brew to holy grail. Aliment Pharmacol Ther 2020;51:208-9. [PMID: 31850583 DOI: 10.1111/apt.15553] [Reference Citation Analysis]
123 Oksi J, Anttila VJ, Mattila E. Treatment of Clostridioides (Clostridium) difficile infection. Ann Med 2020;52:12-20. [PMID: 31801387 DOI: 10.1080/07853890.2019.1701703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
124 Li X, Chu Q, Huang Y, Xiao Y, Song L, Zhu S, Kang Y, Lu S, Xu J, Ren Z. Consortium of Probiotics Attenuates Colonization of Clostridioides difficile. Front Microbiol 2019;10:2871. [PMID: 31921049 DOI: 10.3389/fmicb.2019.02871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
125 Zhang X, Tian H, Chen Q, Qin H, Li N. Fecal microbiota transplantation: standardization or diversification? Sci China Life Sci 2019;62:1714-6. [PMID: 31813093 DOI: 10.1007/s11427-019-1592-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
127 Olesen SW, Gerardin Y. Re-evaluating the evidence for fecal microbiota transplantation “super-donors” in inflammatory bowel disease.. [DOI: 10.1101/19011635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
128 Aira A, Fehér C, Rubio E, Soriano A. The Intestinal Microbiota as a Reservoir and a Therapeutic Target to Fight Multi-Drug-Resistant Bacteria: A Narrative Review of the Literature. Infect Dis Ther 2019;8:469-82. [PMID: 31654298 DOI: 10.1007/s40121-019-00272-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
129 Hsu BB, Way JC, Silver PA. Stable neutralization of virulent bacteria using temperate phage in the mammalian gut.. [DOI: 10.1101/794222] [Reference Citation Analysis]
130 Satokari R. Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics. Nutrients 2019;11:E1921. [PMID: 31443276 DOI: 10.3390/nu11081921] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]